Avedro, a global pharmaceutical and medical device company focused on advancing the science and technologyof corneal cross-linking and refractive correction, engages MESH for the development and implementation of its patient engagement digital strategy to drive awareness and provide educational resources including treatment options to people living with corneal eye disease.
Bill Schick is a Fractional CMO, Agency Founder, and Life Science industry veteran with direct full-cycle experience from discovery and innovation to IPO and exit.
More About
Bill Schick
